US Patent Issued to Blueprint Medicines on April 7 for "Inhibitors of activin receptor-like kinase" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,265, issued on April 7, was assigned to Blueprint Medicines Corp. (Cambridge, Mass.).

"Inhibitors of activin receptor-like kinase" was invented by Natasja Brooijmans (Cambridge, Mass.), Jason D. Brubaker (Cambridge, Mass.), Paul E. Fleming (Cambridge, Mass.), Brian Lewis Hodous (Cambridge, Mass.), Joseph L. Kim (Cambridge, Mass.), Brett D. Williams (Cambridge, Mass.), Douglas Wilson (Cambridge, Mass.), Kevin J. Wilson (Cambridge, Mass.) and Mark Cronin (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of ...